Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Nutriband Inc.
Nutriband Inc. added to the Russell Microcap® Index, Russell Microcap Growth® Index, Russell 3000E® Index and Russell 3000E Growth® Index
July 01, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Tickers
NTRB
NTRBW
Nutriband and Kindeva Complete Commercial Manufacturing Process Scale-up for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
June 18, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Tickers
NTRB
NTRBW
Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology
June 09, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Tickers
NTRB
NTRBW
Nutriband Inc. to present at the 2025 Noble Capital Markets Virtual Equity Conference
June 03, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Tickers
NTRB
NTRBW
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q1, 2025 up 63% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl
June 02, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Tickers
NTRB
NTRBW
Nutriband CEO Publishes Letter to Shareholders
April 30, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Tickers
NTRB
NTRBW
Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology
April 11, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Tickers
NTRB
NTRBW
UPDATE – Nutriband Signs Associate Partnership with Charlotte FC
April 04, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Tickers
NTRB
NTRBW
Nutriband Signs Partnership Agreement with Charlotte FC
April 04, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Tickers
NTRB
NTRBW
Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.
February 21, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Tickers
NTRB
NTRBW
Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
February 13, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Tickers
NTRB
NTRBW
Nutriband Inc. Announces Olympian Anastasia Nichita to Advisory Board
February 11, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Tickers
NTRB
NTRBW
Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™
February 07, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Tickers
NTRB
NTRBW
Nutriband Issues Letter to Shareholders
December 31, 2024
From
Nutriband Inc.
Via
GlobeNewswire
Tickers
NTRB
NTRBW
Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology
December 27, 2024
From
Nutriband Inc.
Via
GlobeNewswire
Tickers
NTRB
NTRBW
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025
December 04, 2024
From
Nutriband Inc.
Via
GlobeNewswire
Tickers
NTRB
NTRBW
Nutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4th
December 04, 2024
From
Nutriband Inc.
Via
GlobeNewswire
Tickers
NTRB
NTRBW
Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology
November 27, 2024
From
Nutriband Inc.
Via
GlobeNewswire
Tickers
NTRB
NTRBW
Nutriband Inc. Announces Seven-for-Six Forward Stock Split
July 27, 2022
From
Nutriband Inc.
Via
AccessWire
Tickers
NTRB
NTRBW
1.2M Shares of Nutriband Inc. to be Cancelled from Total Outstanding Shares Following Final Court Judgment in Favor of the Company
July 26, 2022
From
Nutriband Inc.
Via
AccessWire
Tickers
NTRB
NTRBW
Nutriband Inc. Registers New Company Branch in Ecuador with Plans to Expand into the South American Market
July 22, 2022
From
Nutriband Inc.
Via
AccessWire
Tickers
NTRB
NTRBW
Nutriband Inc. Successfully Obtains Court Verdict for Recovery of Shares Constituting 15% of Its Total Outstanding Shares
July 15, 2022
From
Nutriband Inc.
Via
AccessWire
Topics
Lawsuit
Tickers
NTRB
NTRBW
Nutriband Supports Update to CDC Opioid Prescribing Guidelines
June 03, 2022
From
Nutriband Inc.
Via
AccessWire
Tickers
NTRB
NTRBW
Nutriband Inc. Interview to Air on Bloomberg U.S. on The Redchip Money Report(R)
May 27, 2022
From
Nutriband Inc.
Via
AccessWire
Tickers
NTRB
NTRBW
Nutriband Inc. to Present at the Emerging Growth Conference on May 25
May 20, 2022
From
Nutriband Inc.
Via
AccessWire
Tickers
NTRB
NTRBW
Nutriband Inc. Receives Orders for $230,000 in Contract Manufacturing for First 3 Weeks of May
May 17, 2022
From
Nutriband Inc.
Via
AccessWire
Tickers
NTRB
NTRBW
Nutriband Subsidiary Active Intelligence LLC Registers with FDA as a Medical Device Manufacturer for its AI Kinesiology Tape Product
May 11, 2022
From
Nutriband Inc.
Via
AccessWire
Topics
Artificial Intelligence
Tickers
NTRB
NTRBW
Nutriband Inc. Reports Revenue Up 56% in Fiscal 2022 to a Record $1.4M
April 29, 2022
From
Nutriband Inc.
Via
AccessWire
Tickers
NTRB
Nutriband Inc.'s Patent, 'Abuse and Misuse Deterrent Transdermal System’ Published by the United States Patent and Trademark Office Following Recent Issuance Notice
February 16, 2022
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Tickers
NTRB
NTRBW
Nutriband Inc. To Participate in The Benzinga All Access Event on February 4
February 04, 2022
From
Nutriband Inc.
Via
AccessWire
Tickers
NTRB
NTRBW
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.